Literature DB >> 8399919

Effect of pH, inoculum size, and incubation time on the susceptibility of Ureaplasma urealyticum to erythromycin in vitro.

G E Kenny1, F D Cartwright.   

Abstract

Determinations of the susceptibility of Ureaplasma urealyticum to erythromycin in vitro as measured by the broth dilution method have shown wide variations with minimal inhibitory concentrations (MICs) from 0.04 to > or = 8 micrograms/mL, indicating a need for standardization. The effects of pH, inoculum size, and incubation were studied. In the broth dilution test, pH had an important effect. The apparent MIC was 4- to 16-fold higher at pH 6.0 than at pH 7.0, with the MIC falling progressively from values of 8 to > or = 8 micrograms/mL to values of 0.25 to 1 microgram/mL as the pH of the medium was increased in steps to pH 7.0. Large inocula also inflated the MICs 2- to 4-fold. In addition, the time of incubation influenced the apparent MIC, with increases of 4- to 16-fold between days 1 and 5. In agar dilution assays, MICs decreased from 2 micrograms/mL at pH 6.2 to 0.5 microgram/mL at pH 6.6. Since pH, inoculum level, and incubation time appear to be responsible for most of the variation in results, we propose that susceptibility testing for ureaplasmas can be improved by using medium with a more neutral pH than that usually used (pH 6) and by standardizing the inoculum size and incubation period.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8399919     DOI: 10.1093/clinids/17.supplement_1.s215

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  10 in total

1.  Problems related to determination of MICs of oximino-type expanded-spectrum cephems for Proteus vulgaris.

Authors:  A Ohno; Y Ishii; L Ma; K Yamaguchi
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Effects of inoculum size and incubation time on broth microdilution susceptibility testing of lactic acid bacteria.

Authors:  Maria Egervärn; Hans Lindmark; Stefan Roos; Geert Huys; Sven Lindgren
Journal:  Antimicrob Agents Chemother       Date:  2006-10-23       Impact factor: 5.191

3.  Susceptibilities of neonatal respiratory isolates of Ureaplasma urealyticum to antimicrobial agents.

Authors:  A Matlow; C Th'ng; D Kovach; P Quinn; M Dunn; E Wang
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

4.  Pharmacokinetics, microbial response, and pulmonary outcomes of multidose intravenous azithromycin in preterm infants at risk for Ureaplasma respiratory colonization.

Authors:  L Marcela Merchan; Hazem E Hassan; Michael L Terrin; Ken B Waites; David A Kaufman; Namasivayam Ambalavanan; Pamela Donohue; Susan J Dulkerian; Robert Schelonka; Laurence S Magder; Sagar Shukla; Natalie D Eddington; Rose M Viscardi
Journal:  Antimicrob Agents Chemother       Date:  2014-11-10       Impact factor: 5.191

5.  Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolones.

Authors:  G E Kenny; F D Cartwright
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

6.  Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to new glycylcyclines in comparison with those to older tetracyclines.

Authors:  G E Kenny; F D Cartwright
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

7.  Concurrent titration and determination of antibiotic resistance in ureaplasma species with identification of novel point mutations in genes associated with resistance.

Authors:  Michael L Beeton; Victoria J Chalker; Nicola C Maxwell; Sailesh Kotecha; O Brad Spiller
Journal:  Antimicrob Agents Chemother       Date:  2009-03-09       Impact factor: 5.191

8.  Role of biofilm formation in Ureaplasma antibiotic susceptibility and development of bronchopulmonary dysplasia in preterm neonates.

Authors:  Katherine Pandelidis; Amanda McCarthy; Kirsty L Chesko; Rose M Viscardi
Journal:  Pediatr Infect Dis J       Date:  2013-04       Impact factor: 2.129

9.  Reporter-Based Assays for High-Throughput Drug Screening against Mycobacterium abscessus.

Authors:  Rashmi Gupta; Mandy Netherton; Thomas F Byrd; Kyle H Rohde
Journal:  Front Microbiol       Date:  2017-11-10       Impact factor: 5.640

10.  Ureaplasma parvum serovar 3 multiple banded antigen size variation after chronic intra-amniotic infection/colonization.

Authors:  James W Robinson; Samantha J Dando; Ilias Nitsos; John Newnham; Graeme R Polglase; Suhas G Kallapur; J Jane Pillow; Boris W Kramer; Alan H Jobe; Diane Payton; Christine L Knox
Journal:  PLoS One       Date:  2013-04-26       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.